SCHEMBL6071280

SCHEMBL6071280

CCCn1c2c(c3ccccc31)CCc1c-2n[nH]c1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 7/20 0.49
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 3/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
TSHR P16473 2/20 0.47
MAPK1 P28482 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
AURKA O14965 1/20 0.42
MAPK10 P53779 1/20 0.42
RIPK1 Q13546 1/20 0.42
FABP4 P15090 2/20 0.40
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
KDM4E B2RXH2 3/20 0.39
ALPL P05186 2/20 0.39
CLK1 P49759 1/20 0.39
POLB P06746 2/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6071197 0.94 ALDH1A1 (0.56) PDE5AALDH1A1HSD17B10HPGDMEN1
SCHEMBL6071467 0.91 PDE5A (0.47) PDE5AALDH1A1HSD17B10HPGDMEN1
SCHEMBL6071587 0.86 KDM4E (0.45) PDE5AALDH1A1HSD17B10HPGDMEN1
SCHEMBL6071546 0.85 MAPT (0.48) ALDH1A1HSD17B10MEN1KMT2ATSHR
SCHEMBL6071171 0.80 KDM4E (0.41) PDE5AALDH1A1HSD17B10MEN1KMT2A
SCHEMBL6071119 0.67 AURKA (0.68) ALDH1A1HSD17B10HPGDMEN1KMT2A
SCHEMBL6071191 0.67 KDM4E (0.47) PDE5AALDH1A1HSD17B10HPGDMEN1
SCHEMBL13415776 0.63 ALDH1A1 (0.64) ALDH1A1HPGDKMT2AFABP4KDM4E
SCHEMBL275697 0.63 KDM4E (0.49) PDE5AALDH1A1HSD17B10HPGDMEN1
SCHEMBL30854944 0.62 ALDH1A1 (0.62) ALDH1A1HSD17B10HPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2006-11-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K1, MAP3K19, MAP3K20 PDE5A 2561/4885ALDH1A1 4446/4885HSD17B10 4387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.